King’s College London has launched a COVID-19 symptom-tracking app in the UK. The aim is to help slow the outbreak by tracking in real time: How fast the virus is spreading geographically High-risk areas in the UK Who is most at risk, by better understanding symptoms linked to underlying health conditions The app is free to […]
Tag: personalised medicine
The UK government has announced a new National Genomic Healthcare Strategy which sets out how the UK can become the global leader in genomic healthcare.
Genomics England has selected QIAGEN to provide bioinformatic support to the NHS Genomic Medicine Service and its national network of Genomic Laboratory Hubs for 5 million genome project.
JPND, the EU’s neurodegenerative disease research initiative, has announced a €30 million call for multinational research on personalised medicine for neurodegenerative diseases.
SOPHiA GENETICS has closed a $77 million funding round led by Generation Investment Management, with participation from Idinvest Partners, alongside existing investors including Balderton Capital and Alychlo.